Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission – a case report - Summary - MDSpire
Advertisement
Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission – a case report
To explore the efficacy of an integrative oncology protocol combined with systemic treatments in a specific patient with advanced bladder cancer and metastasis.
Key Findings:
Patient showed excellent tolerance to treatment.
Significant symptomatic relief and normalization of cancer-related biomarkers.
Marked metabolic response with stable residual metabolic activity on PET-CT within six months.
Improved quality of life measures and enhanced survival potential as indicated by the Chuang Survival Score.
Interpretation:
The case suggests that combining systemic cancer therapies with integrative oncology may improve clinical outcomes and quality of life for patients with advanced bladder cancer, but further research is essential.
Limitations:
Findings are based on a single case report, limiting generalizability.
Larger, controlled studies are needed to validate the results.
Conclusion:
Integrative oncology may offer a promising approach to enhance treatment tolerance and quality of life in advanced bladder cancer, warranting further investigation.
